Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary and cardiac diseases. Our mission is to develop well-studied molecules deployed through innovative delivery systems to treat diseases with significant unmet clinical need.
Company Details
- Employees
- 7
- Founded
- -
- Address
- 184 Liberty Corner Rd, Warren,new Jersey 07059,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- bellerophon.com
- HQ
- Warren, New Jersey
Bellerophon Therapeutics Questions
Bellerophon Therapeutics's website is bellerophon.com
Bellerophon Therapeutics's LinkedIn profile is https://www.linkedin.com/company/bellerophon-therapeutics
Bellerophon Therapeutics has
7 employees.
View email and phone details for 7
employees at Bellerophon Therapeutics.
Bellerophon Therapeutics's industry is
Biotechnology Research
Bellerophon Therapeutics's top competitors are
Varsity Pharmaceuticals,
Achieve Life Sciences,
Orphalan,
Cycle Pharmaceuticals,
Avadel Pharmaceuticals Plc,
Beyond Air®,
Mallinckrodt Pharmaceuticals,
Ikaria, Inc. - Now A Part Of Mallinckrodt Pharmaceuticals.,
Astex Pharmaceuticals,
Celularity Inc..
Bellerophon Therapeutics's categories are Biotechnology Research
Bellerophon Therapeutics's founding year is 2014
